Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)

CNY 21.63

(-0.18%)

Market Cap (In CNY)

13.34 Billion

Revenue (In CNY)

1.01 Billion

Net Income (In CNY)

294.61 Million

Avg. Volume

1.96 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
15.22-26.78
PE
-
EPS
-
Beta Value
0.303
ISIN
CNE1000062X2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Yan Li Liu
Employee Count
-
Website
https://www.3s-guojian.com
Ipo Date
2020-07-22
Details
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.

More Stocks